Hence early detection of micrometastasis could find the patients who derived more benefits from neoadjuvant therapy.[ 11 ] Currently, immunohistochemistry (IHC) and polymerase chain reaction (PCR) techniques are used for the detection of micrometastasis.[ 12 13 14 15 16 ] These techniques mainly focus on the detection of cytokeratins as specific marker of epithelial cells that have been evaluated in previous studies.[ 17 18 ] Today, there is an increasing trend in the use of neoadjuvant therapy in CRC patients for treatment of occult metastasis.[ 19 20 21 ] Therefore case selection for this purpose seems to be important.
← all excerpts
The significance of clinicopathological aspects of tumor for the detection of liver micrometastasis in patients with colorectal cancer.
1
—
—